<DOC>
	<DOC>NCT00563498</DOC>
	<brief_summary>The primary purpose of this project is to investigate if addition of glutamine, an amino acid, to standard parenteral nutrition, may improve the clinical outcome of the bone marrrow transplantation reducing the occurrence of veno-occlusive disease and severity of mucositis.</brief_summary>
	<brief_title>Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Hepatic Veno-Occlusive Disease</mesh_term>
	<mesh_term>Pulmonary Veno-Occlusive Disease</mesh_term>
	<criteria>Allogeneic bone marrow transplant recipients using busulfan and cyclophosphamide as conditioning.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Veno-occlusive disease</keyword>
	<keyword>Mucositis</keyword>
</DOC>